-
News Agency News Aggregator Journalist/Editor Broking House Others
Sun Pharma....look at accumulation over past few days
#LMPicks SunPharma Buy call given @ 610.50, 1st Tgt hit @ 628, Book partial & modify SL at cost Disclaimer:
#StocksInNews #SUN PHARMA Gets US FDA Nod For Generic Of Lotemax Eye Drops
Sun Pharma pledge release
Sun Pharma promoter released pledge on 1.1 cr shares from Feb 20-25
In conversation with @NithyaBala84, Director, Sanford Bernstein, @SurabhiUpadhyay @latha_venkatesh @_anujsinghal discuss their top picks from the pharma space. They have an Outperform rating on Cipla & Sun Pharma and are the top picks from the sector, she says
Ravindra Soni, editor, businessfortnight.com
Sun Pharma Urgent Opening for Production Quality Control Engineering ETP Apply Now
Sun Pharma posts website for its LTC division in US
SUNPHARMA Now @ 619 Look @ 25-Mar-2021 , 620 CE NOW @ 29.65 #sunpharma #sp
Sun pharma below 600
Sun Pharma posts website for its LTC division in US
Sun Pharma announces website for LTC portfolio in US
Sun Pharma jumps after launching website for long-term care division in US #StockMarket #SunPharmaceuticalsIndustries #StockOnMove #Investmentguruindia
#SunPharma including its subsidiaries and/or associate companies) announced the U.S. launch of the website for its long-term care (LTC) division.
#LMPicks Trading Call : Buy SunPharma @ 610.50, SL 593, Tgts 628-644. Disclaimer:
Sun Pharma has launched a website ‘’ for its long-term care division in the US
#SunPharma
Anti-IL drug sales in the US up 31.5% in 2020, implying strong demand. Strong market trends should support Ilumya pick-up, HSBC says, maintains BUY on Sun Pharma with target of Rs 700/sh
-